Coexpression of bone sialoprotein (BSP) and the pivotal transcriptional regulator of osteogenesis, Cbfa1/Runx2, in malignant melanoma

Calcified Tissue International

Volumn 73, Issue 3, 2003, Pages 281-289

  Riminucci, M ^a   Corsi, A ^d   Peris, K ^e   Fisher, L W ^b   Chimenti, S ^c   Bianco, P ^a,d  

^a Biomedical Science Park San Raffaele   (Italy)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e NONE

Author keywords

Bone sialoprotein; Cancer; Cbfa1; Cell lines; Immunohistology; Melanoma; mRNA

Indexed keywords

COLLAGENASE 3; INTEGRIN; MATRIX METALLOPROTEINASE 14; OSTEOPONTIN; PROTEIN; SIALOPROTEIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ARTICLE; BONE DEVELOPMENT; BONE METASTASIS; CANCER INVASION; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; MELANOMA; MESODERM; MESSENGER RNA SYNTHESIS; METASTASIS POTENTIAL; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; TRANSCRIPTION REGULATION;

CELL LINE, TUMOR; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DNA PRIMERS; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MICROSCOPY, FLUORESCENCE; NEOPLASM PROTEINS; NEOPLASM STAGING; OSTEOBLASTS; OSTEOSARCOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SIALOGLYCOPROTEINS; SKIN NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 0141857824     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-002-2134-y     Document Type: Article

References (65)

1. Fisher LW, Torchia DA, Fohr B, Young MF, Fedarko NS (2001) Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. Biochem Biophys Res Commun 280:460-465
2. Fisher LW, Hawkins SW, Tuross N, Termine JD (1983) Purification and partial characterization of bone proteoglycans I and II, bone sialoproteins I and II and osteonectin from the mineral compartment of the human bone. J Biol Chem 262:9702-9708
3. Zaia J, Boynton R, Heinegard D, Barry F (2001) Posttranslational modifications to human bone sialoprotein determined by mass spectrometry. Biochemistry 40:12983-12991
4. Bianco P, Fisher LW, Young MF, Termine JD, Robey PG (1991) Expression of bone sialoprotein (BSP) in developing human tissues. Calcif Tissue Int 49:421-426
5. Bianco P, Riminucci M, Bonucci E, Termine JD, Robey PG (1993) Bone sialoprotein (BSP) secretion and osteoblast differentiation: relationship to bromodeoxyuridine incorporation, alkaline phosphatase, and matrix deposition. J Histochem Cytochem 41:183-191
6. Chen J, Shapiro HS, Sodek J (1992) Development expression of bone sialoprotein mRNA in rat mineralized connective tissues. J Bone Miner Res 7:987-997
7. Riminucci M, Silvestrini G, Bonucci E, Fisher LW, Gehron Robey P, Bianco P (1995) The anatomy of bone sialoprotein immunoreactive sites in bone as revealed by combined ultrastructural histochemistry and immunohistochemistry. Calcif Tissue Int 57:277-284
8. Riminucci M, Bradbeer JN, Corsi A, Gentili C, Descalzi R, Cancedda R, Bianco P (1998) Vis-a-vis cells and the priming of bone formation. J Bone Miner Res 13:1852-1861
9. Bellahcene A, Maloujahmoum N, Fisher LW, Pastorino E, Tagliabue E, Menard S, Castronovo V (1997) Expression of bone sialoprotein in human lung cancer. Calcif Tissue Int 61:183-188
10. Bellahcene A, Albert V, Pollina L, Basolo F, Fisher LW, Castronovo V (1998) Ectopic expression of bone sialoprotein in human thyroid cancer. Thyroid 8:637-641
11. Bellahcene A, Merville MP, Castronovo V (1994) Expression of bone sialoprotein, a bone matrix protein, in human breast cancer. Cancer Res 54:2823-2826
12. Bellahcene A, Antoine N, Clausse N, Tagliabue E, Fisher JM, Kerr JM, Jares P, Castronovo V (1996) Detection of bone sialoprotein in human breast cancer tissue and cell lines at both protein and messenger ribonucleic acid levels. Lab Invest 75:203-210
13. Ibrahim T, Leong I, Sanchez-Sweatman O, Khokha R, Sodek J, Tenenbaum HC, Ganss B, Cheifetz S (2000) Expression of bone sialoprotein and osteopontin in breast cancer bone metastases. Clin Exp Metastasis 18:253-260
14. Waltregny D, Bellahcene A, Van Riet I, Fisher LW, Young M, Fernandez P, Dewe W, de Leval J, Castronovo V (1998) Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer. J Natl Cancer Inst 90:1000-1008
15. Waltregny D, Bellahcene A, de Leval X, Florkin B, Weidle V, Castronovo V (2000) Increased expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancers. J Bone Miner Res 15:834-843
16. Fedarko NS, Jain A, Karadag A, Van Eman MR, Fisher LW (2001) Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res 7:4060-4066
17. Bianco P, Riminucci M, Silvestrini G, Bonucci E, Termine LW, Fisher LW, Robey PG (1993) Localization of bone sialoprotein (BSP) to Golgi and post-Golgi secretory structures in osteoblasts and to discrete sites in early bone matrix. J Histochem Cytochem 41:193-203
18. Hunter GK, Goldberg HA (1993) Nucleation of hydroxyapatite by bone sialoprotein. Proc Natl Acad Sci USA 90:8562-8565
19. Oldberg A, Franzen A, Heinegard D, Pierschbacher M, Ruoslahti E (1988) Identification of a bone sialoprotein receptor in osteosarcoma cells. J Biol Chem 263:19433-19436
20. Oldberg A, Franzen A, Heinegard D (1988) The primary structure of a cell-binding bone sialoprotein. J Biol Chem 263:19430-19432
21. Bellahcene A, Castronovo V (1997) Expression of bone matrix proteins in human breast cancer: potential roles in microcalcification formation and in the genesis of bone metastases. Bull Cancer 84:17-24
22. Castronovo V, Bellahcene A (1998) Evidence that breast cancer associated microcalcifications are mineralized malignant cells. Int J Oncol 12:305-308
23. Bellahcene A, Kroll M, Liebens F, Castronovo V (1996) Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development. J Bone Miner Res 11:665-670
24. Diel IJ (2001) Prognostic factors for skeletal relapse in breast cancer. Cancer Treat Rev 27:153-157; discussion 159-164
25. Withold W, Armbruster FP, Karmatschek M, Reinauer H (1997) Bone sialoprotein in serum of patients with malignant bone diseases. Clin Chem 43:85-91
26. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G (1997) OSF2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:1-20
27. Komori T, Yagi H, Nomura S et al. (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764
28. Otto F, Thornell AP, Crompton T et al. (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765 771
29. Jimenez MJ, Balbin M, Lopez JM, Alvarez J, Komori T, Lopez-Otin C (1999) Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation. Mol Cell Biol 19:4431-4442
30. Jimenez MJ, Balbin M, Alvarez J et al. (2001) A regulatory cascade involving retinoic acid, Cbfa1, and matrix metalloproteinases is coupled to the development of a process of perichondrial invasion and osteogenic differentiation during bone formation. J Cell Biol 155:1333-1344
31. Cox G, O'Byrne KJ (2001) Matrix metalloproteinases and cancer. Anticancer Res. 21:4207-4219
32. Hofmann UB, Westphal JR, Van Muijen GN, Ruiter DJ (2000) Matrix metalloproteinases in human melanoma. J Invest Dermatol 115:337-344
33. Airola K, Karonen T, Vaalamo M et al. (1999) Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and-3 correlates with the level of invasion in malignant melanomas. Br J Cancer 80:733-743
34. Fisher LW, Stubbs JT, Young MF (1995) Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop Scand S266:61-65
35. Rodan SB, Wesolowski G, Thomas K, Rodan GA (1987) Growth stimulation of rat calvaria osteoblastic cells by acidic fibroblast growth factor. Endocrinology 121:1917-1923
36. Midura RJ, McQuillan DJ, Benham KJ, Fisher LW, Hascall VC (1990) A rat osteogenic cell line (UMR 106-01) synthesizes a highly sulfated form of bone sialoprotein. J Biol Chem 265:5285-5291
37. Mundlos S, Otto F, Mundlos C et al. (1997) Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89:773-779
38. Xiao ZS, Thomas R, Hinson TK, Quarles LD (1998) Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor. Gene 214:187-197
39. Yeh GL, Mathur S, Wivel A et al. (2000) GNAS1 mutation and Cbfa1 misexpression in a child with severe congenital platelike osteoma cutis. J Bone Miner Res 15:2063-2073
40. Helfrich MH, Nesbitt SA, Dorey EL, Horton MA (1992) Rat osteoclasts adhere to a wide range of RGD (Arg-Gly-Asp) peptide-containing proteins, including the bone sialoproteins and fibronectin, via a beta 3 integrin. J Bone Miner Res 7:335-343
41. Zhou L, Zhang SR, Yue BY (1996) Adhesion of human trabecular meshwork cells to extracellular matrix proteins. Roles and distribution of integrin receptors. Invest Ophthalmol Vis Sci 37:104-113
42. Bellahcene A, Bonjean K, Fohr B et al. (2000) Bone sialoprotein mediates human endothelial cell attachment and migration and promotes angiogenesis. Circ Res 86:885-891
43. Byzova TV, Kim W, Midura RJ, Plow EF (2000) Activation of integrin alpha(V)beta(3) regulates cell adhesion and migration to bone sialoprotein. Exp Cell Res 254:299-308
44. Fedarko NS, Fohr B, Robey PG, Young MF, Fisher LW (2000) Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack. J Biol Chem 275:16666-16672
45. Mintz KP, Grzesik WJ, Midura RJ, Robey PG, Termine LW, Fisher LW (1993) Purification and fragmentation of nondenatured bone sialoprotein: evidence for a cryptic, RGD-resistant cell attachment domain. J Bone Miner Res 8:985-995
46. Harris NL, Rattray KR, Tye CE et al. (2000) Functional analysis of bone sialoprotein: identification of the hydroxyapatite-nucleating and cell-binding domains by recombinant peptide expression and site-directed mutagenesis. Bone 27:795-802
47. Vaillant F, Blyth K, Terry A, Bell M, Cameron ER, Neil J, Stewart M (1999) A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc. Oncogene 18:7124-7134
48. Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffrey V, Amling M, Karsenty G (1999) A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 13:1025-1036
49. Benson MD, Aubin JE, Xiao G, Thomas PE, Franceschi RT (1999) Cloning of a 2,5 kb murine bone sialoprotein promoter fragment and functional analysis of putative Osf2 binding sites. J Bone Miner Res 14:396-405
50. Jiang H, Sodek J, Karsenty G, Thomas H, Ranly D, Chen J (1999) Expression of core binding factor Osf2/Cbfa-1 and bone sialoprotein in tooth development. Mech Dev 81:169-173
51. Javed A, Barnes GL, Jasanya BO, Stein JL, Gerstenfeld L, Lian JB, Stein GS (2001) Runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: evidence for promoter context-dependent activity of Cbfa proteins. Mol Cell Biol 21:2891-2905
52. Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN (2000) Expression and activation of matrix metalloproteinase-2 (MMP-2) and its colocalization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. J Pathol 191:245-256
53. Varner JA, Cheresh DA (1996) Integrins and cancer. Curr Opin Cell Biol 8:724-730
54. Hofmann UB, Westphal JR, Waas ET, Becker JC, Ruiter GN, van Muijen GN (2000) Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression. J Invest Dermatol 115:625-632
55. Holmbeck K, Bianco P, Caterina J et al. (1999) MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99:81-92
56. Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, Bissell MJ (1997) Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol 139:1861-1872
57. Gonzalez-Licea A, Yardley JH, Hartmann WH (1967) Malignant tumor of the breast with bone formation. Studies by light and electron microscopy. Cancer 20:1234-1247
58. An T, Grathwohl M, Frable WJ (1984) Breast carcinoma with osseous metaplasia: an electron microscopic study. Am J Clin Pathol 81:127-132
59. Banerjee SS, Coyne JD, Menasce LP, Lobo CJ, Hirsch PJ (1998) Diagnostic lessons of mucosal melanoma with osteocartilaginous differentiation. Histopathology 33:255-260
60. Friedmann I (1998) Osteoid and bone formation in a nasal mucosal melanoma and its metastasis. Histopathology 33:88
61. Hoorweg JJ, Loftus BM, Hilgers FJ (1997) Osteoid and bone formation in a nasal mucosal melanoma and its metastasis. Histopathology 31:465-468
62. Lucas DR, Tazelaar HD, Unni KK, Wold LE, Okada K, Dimarzio Jr. DJ, Rolfe B (1993) Osteogenic melanoma. A rare variant of malignant melanoma. Am J Surg Pathol 17:400-409
63. Moreno A, Lamarca J, Martinez R, Guix M (1986) Osteoid and bone formation in desmoplastic malignant melanoma. J Cutan Pathol 13:128-134
64. Lin DL, Tarnowski CP, Zhang J, Dai J, Rohn E, Patel MD, Morris MD, Keller ET (2001) Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro. Prostate 47:212-221
65. Selvamurugan N, Partridge NC (2000) Constitutive expression and regulation of collagenase-3 in human breast cancer cells. Mol Cell Biol Res Commun 3:218-223